Lynx1 Capital Management Lp Top Holdings and 13F Report (2026) About Lynx1 Capital Management LpInvestment ActivityLynx1 Capital Management Lp has $646.09 million in total holdings as of September 30, 2026.Lynx1 Capital Management Lp owns shares of 31 different stocks, but just 3 companies or ETFs make up 80% of its holdings.Approximately 2.96% of the portfolio was purchased this quarter.About 16.19% of the portfolio was sold this quarter.This quarter, Lynx1 Capital Management Lp has purchased 27 new stocks and bought additional shares in 6 stocks.Lynx1 Capital Management Lp sold shares of 2 stocks and completely divested from 2 stocks this quarter.Largest Holdings GH Research $311,422,002Cullinan Therapeutics $137,589,725Stoke Therapeutics $101,300,394C4 Therapeutics $25,077,947PRECISION BIOSCIENCES INC $17,266,426 Largest New Holdings this Quarter 48669G303 - KAZIA THERAPEUTICS LTD $2,166,551 Holding86889P208 - SURROZEN INC $643,600 Holding92941V407 - YARROW BIOSCIENCE INC $495,440 Holding45258D105 - Immunocore $433,147 Holding26818M108 - DYNE THERAPEUTICS INC $402,750 Holding Largest Purchases this Quarter PRECISION BIOSCIENCES INC 1,807,749 shares (about $11.32M)KAZIA THERAPEUTICS LTD 225,800 shares (about $2.17M)ProQR Therapeutics 1,040,680 shares (about $1.73M)C4 Therapeutics 204,224 shares (about $680.07K)SURROZEN INC 20,000 shares (about $643.60K) Largest Sales this Quarter Agios Pharmaceuticals 2,936,331 shares (about $97.63M)Stoke Therapeutics 142,235 shares (about $3.70M) Sector Allocation Over TimeMap of 500 Largest Holdings ofLynx1 Capital Management Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorGHRSGH Research$311,422,0020.0%13,263,28848.2%HealthcareCGEMCullinan Therapeutics$137,589,7250.0%8,963,50021.3%HealthcareSTOKStoke Therapeutics$101,300,394$3,698,110 ▼-3.5%3,896,16915.7%HealthcareCCCCC4 Therapeutics$25,077,947$680,066 ▲2.8%7,530,9153.9%HealthcarePRECISION BIOSCIENCES INC$17,266,426$11,316,509 ▲190.2%2,758,2152.7%COM NEWAGIOAgios Pharmaceuticals$15,714,150$97,633,009 ▼-86.1%472,6062.4%HealthcareKORRO BIO INC$15,310,752$66,238 ▲0.4%1,544,9802.4%COMNEUPHORIA THERAPEUTICS INC$3,116,1680.0%875,3280.5%COMPASSAGE BIO INC$3,031,9140.0%673,7590.5%COM NEWPRQRProQR Therapeutics$2,593,074$1,727,529 ▲199.6%1,562,0930.4%HealthcareTCRXTScan Therapeutics$2,522,0220.0%8,019,1480.4%HealthcareKAZIA THERAPEUTICS LTD$2,166,551$2,166,551 ▲New Holding225,8000.3%SPONSORED ADSPLRXPliant Therapeutics$1,941,9160.0%1,798,0700.3%HealthcareTRDAEntrada Therapeutics$1,769,148$635,000 ▲56.0%278,6060.3%HealthcareSURROZEN INC$643,600$643,600 ▲New Holding20,0000.1%COM NEWIMTXImmatics$625,689$421,677 ▲206.7%71,2630.1%HealthcareHOWLWerewolf Therapeutics$606,6760.0%657,7860.1%HealthcareYARROW BIOSCIENCE INC$495,440$495,440 ▲New Holding22,0000.1%COMXNCRXencor$453,9400.0%18,1940.1%HealthcareIMCRImmunocore$433,147$433,147 ▲New Holding14,3000.1%HealthcareDYNE THERAPEUTICS INC$402,750$402,750 ▲New Holding25,0000.1%COMTRAWS PHARMA INC$332,2130.0%559,4700.1%COM NEWDNLIDenali Therapeutics$240,9710.0%11,6580.0%HealthcareABSIAbsci$228,8090.0%21,2450.0%HealthcareFHTXFoghorn Therapeutics$219,8690.0%61,5880.0%HealthcareAVALO THERAPEUTICS INC$154,8330.0%10,1000.0%COM NEWPRIME MEDICINE INC$137,475$137,475 ▲New Holding45,0000.0%COMBOLT BIOTHERAPEUTICS INC$113,3440.0%30,8000.0%COM NEWEUPRAXIA PHARMACEUTICALS INC$91,0000.0%10,0000.0%COMNUVBNuvation Bio$89,7620.0%16,0290.0%HealthcareINHIBIKASE THERAPEUTICS INC$1,2010.0%20,0000.0%COM NEWCG ONCOLOGY INC$0$2,230,331 ▼-100.0%00.0%COMVYNE THERAPEUTICS INC$0$1,059,795 ▼-100.0%00.0%COMShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.